24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BiondVax
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:26
Microsoft explains how Generative AI impacts IP law and compliance
09:25
Airwallex sees Israel as a key player in the GenAI space
09:13
AI transformation doesn’t stop at big financial institutions
08:27
Nvidia continues Israel shopping spree with acquisition of Deci
More stories
Buzz
Most popular
Daily
Weekly
1
Nvidia on verge of completing $700 million acquisition of Run:ai
2
Nvidia announces $700 million acquisition of Run:ai
3
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
4
Nagomi Security raises $23 million Series A for proactive defense platform
5
Bill Ackman: "Israel needs support more than ever and I can help"
More news
BiondVax
2 stories about BiondVax
Flu Season Might Soon Pass, for Good
11.12.19
|
Lilach Baumer
The researchers behind Jerusalem-based BiondVax talked to Calcalist, discussing their potential universal flu vaccine, currently undergoing a phase 3 clinical trial
Marius Nacht Buys Controlling Stake in Universal Flu Vaccine Developer BiondVax
17.07.19
|
Micky Grunfeld
Based in Jerusalem, Nasdaq-listed BiondVax develops a universal flu vaccine, currently in advanced clinical trials
Please ensure Javascript is enabled for purposes of
website accessibility
